Reduced prevalence of allergic disease in patients with multiple sclerosis is associated with enhanced IL-12 production

Journal of Allergy and Clinical Immunology

Volumn 102, Issue 3, 1998, Pages 428-435

  Tang, Lily ^a   Benjaponpitak, Suwat ^a   DeKruyff, Rosemarie H ^a   Umetsu, Dale T ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Allergy; Autoimmune disease; IL 12; Multiple sclerosis

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN E; INTERLEUKIN 12; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 4;

ADULT; ALLERGIC DISEASE; ARTICLE; ATOPY; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; FEMALE; HELPER CELL; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MONOCYTE; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

EID: 0031663155     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70131-9     Document Type: Article

References (34)

1. Navikas V, Link H. Review: cytokines and the pathogenesis of multiple sclerosis. J Neurosci Res 1996;45:322-33.
2. Drulovic J, Mostarica-Stojkovic M, Levic Z, Stojsavljevic N, Pravica V, Mesaros S. Interleukin-12 and tumor necrosis factor-alpha levels in cerebrospinal fluid of multiple sclerosis patients. J Neurol Sci 1997;147:145-50.
3. Robinson D, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley A, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298.
4. Marshall J, Wen Y, Abrams J, Umetsu D. In vitro synthesis of IL-4 by human CD4+ T cells requires repeated antigenic stimulation. Cell Immunol 1993;152:18-34.
5. Secrist H, DeKruyff R, Umetsu D. Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J Exp Med 1995;181:1081-9.
6. Oro A, Guarino T, Driver R, Steinman L, Umetsu D. Regulation of disease susceptibility: decreased prevalence of IgE-mediated allergic disease in patients with multiple sclerosis. J Allergy Clin Immunol 1996;97:1402-8.
7. Neukirch F, Lyon-Caen O, Clanet M, Bousquet J, Feingold J, Druet P. Asthma, nasal allergies, and multiple sclerosis. J Allergy Clin Immunol 1997;99:270-1.
8. Karpuj M, Steinman L, Oksenberg J. Multiple sclerosis: a polygenic disease involving epistatic interactions, germline rearrangements and environmental effects. Neurogenetics 1997;1:21-8.
9. Postma D, Bleecker E, Amelung P, Holroyd K, Xu J, Panhuysen C, et al. Genetic susceptibility to asthma-bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med 1995;333:894-900.
10. Hsieh C, Macatonia S, O'Garra A, Murphy K. T cell genetic background determines default T helper phenotype development in vitro. J Exp Med 1995;181:713-21.
11. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995;13:251-76.
12. Manetti R, Parronchi P, Giudizi M, Piccinni M, Maggi E, Trinchieri G, et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993;177:1199-204.
13. Poser C, Paty D, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
14. Marshall J, Secrist H, DeKruyff R, Wolf S, Umetsu D. IL-12 inhibits the production of IL-4 and IL-10 in allergen-specific human CD4+ T lymphocytes. J Immunol 1995;155:111-7.
15. Gilliland G, Perrin S, Blanchard K, Bunn H. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci U S A 1990;87:2725-9.
16. Weiner L, Ellison G. A working protocol to be used as a guideline for trial in multiple sclerosis. Arch Neurol 1983;40:704-10.
17. Balashov K, Smith D, Khoury S, Hafler D, Weiner H. Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand. Proc Natl Acad Sci U S A 1997;94:599-603.
18. Nicoletti F, Patti F, Cocuzza C, Zaccone P, Nicoletti A, Marco RD, et al. Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis. J Neuroimmunol 1996;70:87-90.
19. DeKruyff RH, Umetsu DT. Antigen-driven but not LPS-driven IL-12 production requires direct interaction between CD40 and CD40L. J Immunol 1997;158:359-66.
20. McRae BL, Picker LJ, van Seventer GA. Human recombinant interferon-beta influences T helper subset differentiation by regulating cytokine secretion pattern and expression of homing receptors. Eur J Immunol 1997;27:2650-6.
21. Blotta MH, DeKruyff RH, Umetsu DT. Corticosteroids inhibit interleukin- 12 production in macrophages and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. J Immunol 1997;158:5589-95.
22. van der Pouw Kraan T, Boeije L, Groot E, Stapel S, Snijders A, Kapsenberg M, et al. Reduced production of IL-12 and IL-12-dependent IFN-gamma release in patients with allergic asthma. J Immunol 1997;158:5560-5.
23. Santambrogio L, Crisi G, Leu J, Hochwald G, Ryan T, Thorbecke G. Tolerogenic forms of auto-antigens and cytokines in the induction of resistance to experimental allergic encephalomyelitis. J Neuroimmunol 1995;58:211-22.
24. Leonard J, Waldburger K, Schaub R, Smith T, Hewson A, Cuzner M, et al. Regulation of the inflammatory response in animal models of multiple sclerosis by interleukin-12. Crit Rev Immunol 1997;17:545-53.
25. Kim TS, DeKruyff RH, Rupper R, Maecker HT, Levy S, Umetsu DT. An OVA-IL-12 fusion protein is more effective than OVA plus rIL-12 in inducing a Th1-dominated immune response and inhibiting antigen-specific IgE production. J Immunol 1997;158:4137-44.
26. Windhagen A, Newcombe J, Dangond F, Strand C, Woodroofe M, Cuzner M, et al. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J Exp Med 1995;182:1985-96.
27. Gieni RS, Fang Y, Trinchieri G, Umetsu DT, DeKruyff RH. Differential production of IL-12 in distinct mouse strains controls Th1 versus Th2 cytokine profiles in primed CD4 lymphocytes. Intern Immunol 1996;8:1511-20.
28. Compston D. Genetic factors in the aetiology of multiple sclerosis. In: McDonald W, Silberberg D, editors. Multiple sclerosis: BIMR Neurology. London: Butterworths; 1986. p 56-73.
29. Marsh D, Neely J, Breazeale D, Ghosh B, Freidhoff L, Ehrlich- Kautzky E, et al. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 1994;264:1152-6.
30. Meyers D, Postma D, Panhuysen C, Xu J, Amelung P, Levitt R, et al. Evidence for a locus regulating total serum IgE levels mapping to chromosome 5. Genomics 1994;23:464-70.
31. Sieburth D, Jabs E, Warrington J, Li X, Lasota J, LaForgia S, et al. Assign-ment of genes encoding a unique cytokine (IL12) composed of two unrelated subunits to chromosomes 3 and 5. Genomics 1992;14:59-62.
32. Lindegard B. Disease associated with multiple sclerosis and epilepsy: a population cohort study of 159,200 middle-aged, urban, native Swedes observed over 10 years(1970-79). Acta Neurol Scand 1985;71:267-77.
33. Saltine S, Bert R, Salem N, Psychorrhea P, Flamboyant L, Celebres P, et al. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV6 DNA. Nat Med 1997;3:1394-7.
34. Shaw M, Lorens J, Dhawan A, DalCanto R, Tse H, Tran A, et al. Local delivery of interleukin 4 by retro virus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J Exp Med 1997;185:1711-4.